Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.28 USD | -5.82% | -0.85% | -9.29% |
Financials (USD)
Sales 2024 * | 5.43M | Sales 2025 * | 33.37M | Capitalization | 29.9M |
---|---|---|---|---|---|
Net income 2024 * | -29M | Net income 2025 * | -7M | EV / Sales 2024 * | 5.51 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.9 x |
P/E ratio 2024 * |
-1.1
x | P/E ratio 2025 * |
-4.96
x | Employees | 25 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.35% |
Latest transcript on Daré Bioscience, Inc.
1 day | +0.68% | ||
1 week | -38.69% | ||
Current month | -39.35% | ||
1 month | -37.86% | ||
3 months | -5.83% | ||
6 months | -31.91% | ||
Current year | -3.79% |
Managers | Title | Age | Since |
---|---|---|---|
Sabrina Johnson
FOU | Founder | 57 | 14-12-31 |
Annie Thurman
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Jessica Hatheway
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robin Steele
BRD | Director/Board Member | 68 | 14-12-31 |
Cheryl Blanchard
BRD | Director/Board Member | 59 | 19-11-19 |
Chairman | 75 | 13-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.28 | -5.82% | 306 203 |
24-04-23 | 0.2973 | +0.68% | 323,196 |
24-04-22 | 0.2953 | +5.46% | 165,190 |
24-04-19 | 0.28 | -5.12% | 555,803 |
24-04-18 | 0.2951 | +4.39% | 975,780 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.79% | 29.9M | |
+3.13% | 43.43B | |
+48.54% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |
- Stock Market
- Equities
- DARE Stock